Potential combination of ibrutinib with gamma delta T-cell therapy in CLL
Iris de Weerdt
CLL2-GIVe trial: investigating chemotherapy-free treatment of CLL
Side-effect of idelalisib and its use in chronic lymphocytic leukemia
The success story of indolent disease treatment expanded to difficult-to-treat patient groups
What leads to shorter progression-free survival in CLL patients?